Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Sees Large Drop in Short Interest

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 500 shares, a decline of 16.7% from the November 15th total of 600 shares. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is currently 0.8 days.

Mosaic ImmunoEngineering Price Performance

CPMV remained flat at $1.00 during trading on Monday. 26 shares of the company traded hands, compared to its average volume of 902. The stock has a 50 day moving average of $0.92 and a 200-day moving average of $0.81. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13. The stock has a market capitalization of $7.24 million, a P/E ratio of -6.67 and a beta of 0.15.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.